Clinical Trial Update: The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma

View source ↗

Summary

ClinicalTrials.gov update describes a study examining the effect of mepolizumab on structural and inflammatory cells in adults with severe eosinophilic asthma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Asthma; Eosinophilic | Status: ACTIVE_NOT_RECRUITING